» Articles » PMID: 36145418

Effect of Probiotics on Host-Microbiota in Bacterial Infections

Overview
Journal Pathogens
Date 2022 Sep 23
PMID 36145418
Authors
Affiliations
Soon will be listed here.
Abstract

Diseases caused by bacteria cause millions of deaths every year. In addition, the problem of resistance to antibiotics is so serious that it threatens the achievements of modern medicine. This is a very important global problem as some bacteria can also develop persistence. Indeed, the persistence of pathogenic bacteria has evolved as a potent survival strategy to overcome host organisms' defense mechanisms. Additionally, chronic or persistent infections may be caused by persisters which could facilitate antibiotic resistance. Probiotics are considered good bacteria. It has been described that the modulation of gut microbiota by probiotics could have a great potential to counteract the deleterious impact and/or regulate gut microbiota after bacterial infection. Probiotics might provide health benefits through the inhibition of pathogen growth or the replacement of pathogenic bacteria. Bearing in mind that current strategies to avoid bacterial persistence and prevent antibiotic resistance are not effective, other strategies need to be assessed. We have carried out a comprehensive review, which included the reported literature between 2016 and 2021, highlighting the clinical trials that reported the probiotics' potential to regulate gut microbiota after bacterial infection and focusing in particular on the context of antibiotic resistance and persister cells.

Citing Articles

Preventive effect of probiotics on infections following colorectal cancer surgery: An umbrella meta-analysis.

Han Y, Wang Y, Guan M World J Gastrointest Surg. 2024; 16(11):3546-3558.

PMID: 39649207 PMC: 11622088. DOI: 10.4240/wjgs.v16.i11.3546.


Employment of Spore-Forming Probiotics to Combat Persister Cells of .

Kheirjou S, Hosseini F, Masjedian Jazi F, Torbati E Rep Biochem Mol Biol. 2024; 12(4):643-651.

PMID: 39086592 PMC: 11288240. DOI: 10.61186/rbmb.12.4.643.


Unraveling the Microbial Symphony: Impact of Antibiotics and Probiotics on Infant Gut Ecology and Antibiotic Resistance in the First Six Months of Life.

Qi Q, Wang L, Zhu Y, Li S, Gebremedhin M, Wang B Antibiotics (Basel). 2024; 13(7).

PMID: 39061284 PMC: 11274100. DOI: 10.3390/antibiotics13070602.


Methicillin Resistant : Molecular Mechanisms Underlying Drug Resistance Development and Novel Strategies to Combat.

Abebe A, Birhanu A Infect Drug Resist. 2023; 16:7641-7662.

PMID: 38111667 PMC: 10726795. DOI: 10.2147/IDR.S428103.


Transcriptomics of : metabolism patterns and cellular responses under high-density culture conditions.

Li L, Zhang H, Meng D, Yin H Front Bioeng Biotechnol. 2023; 11:1274020.

PMID: 37901845 PMC: 10601642. DOI: 10.3389/fbioe.2023.1274020.


References
1.
Rauseo A, Hink T, Reske K, Seiler S, Bommarito K, Fraser V . A randomized controlled trial of GG on antimicrobial-resistant organism colonization. Infect Control Hosp Epidemiol. 2021; 43(2):167-173. DOI: 10.1017/ice.2021.94. View

2.
Brandon A, Garcia A, Khlystov N, Wu W, Criddle C . Enhanced Bioavailability and Microbial Biodegradation of Polystyrene in an Enrichment Derived from the Gut Microbiome of (Mealworm Larvae). Environ Sci Technol. 2021; 55(3):2027-2036. DOI: 10.1021/acs.est.0c04952. View

3.
Jeppsson B, Mangell P, Thorlacius H . Use of probiotics as prophylaxis for postoperative infections. Nutrients. 2012; 3(5):604-12. PMC: 3257690. DOI: 10.3390/nu3050604. View

4.
Hibbing M, Fuqua C, Parsek M, Peterson S . Bacterial competition: surviving and thriving in the microbial jungle. Nat Rev Microbiol. 2009; 8(1):15-25. PMC: 2879262. DOI: 10.1038/nrmicro2259. View

5.
Tonucci L, Santos K, Ferreira C, Ribeiro S, Oliveira L, Martino H . Gut microbiota and probiotics: Focus on diabetes mellitus. Crit Rev Food Sci Nutr. 2015; 57(11):2296-2309. DOI: 10.1080/10408398.2014.934438. View